Scott A. Ritterman

Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee Arthroplasty

John R. Tuttle, Scott A. Ritterman, Dale B. Cassidy et al. · The Journal of Arthroplasty · 2014 · 117 citations

Osteoarthritis, Orthopaedics, Surgery +7

Effects of Tranexamic Acid Cytotoxicity on In Vitro Chondrocytes.

John R. Tuttle, Peter R Feltman, Scott A. Ritterman et al. · PubMed · 2015 · 47 citations

Regenerative Medicine, Tissue Engineering, Vitro Chondrocytes +14

Intraoperative Femur Fracture Risk During Primary Direct Anterior Approach Cementless Total Hip Arthroplasty With and Without a Fracture Table

Eric M. Cohen, Joshua Vaughn, Scott A. Ritterman et al. · The Journal of Arthroplasty · 2017 · 45 citations

Skeletal Trauma, Fracture Table, Hip Arthroplasty +6

Predicting Pulmonary Embolus in Orthopedic Trauma Patients Using the Wells Score

Matthew D. Young, Alan H. Daniels, Peter Evangelista et al. · Orthopedics · 2013 · 17 citations

Trauma Resuscitation, Traumatology, Diagnosis +26

Hip Resection Arthroplasty

Lee E. Rubin, Kenneth T. Murgo, Scott A. Ritterman et al. · JBJS Reviews · 2014 · 16 citations

Critical Care Medicine, Kenneth T. Bs, Hip Arthroplasty +12